Case | Age | Sex |
Glaucoma/ IOP >21 mm Hg | Duration of visual loss (days) | Initial VA | Cause of visual loss | VA at day 1 | Last VA | Rubeosis/ NVG | Follow up (months) |
1 | 66 | F | Yes | 0.5 | CF | IBF | 20/40 | 20/50 | — | 16 |
2 | 53 | M | — | 1 | 20/400 | IBF | 20/50 | 20/20 | — | 6 |
3 | 45 | M | — | 0.5 | CF | IBF | 20/20 | 20/20 | — | 5 |
4 | 67 | M | Yes | 2 | 20/160 | IBF | 20/100 | 20/50 | — | 4 |
5 | 59 | M | — | 11 | CF | IBF | CF | CF | Rubeosis | 28 |
6 | 44 | M | — | 2 | CF | IBF | CF | CF | — | 3 |
7 | 58 | F | — | 0.5 | CF | IBF | CF | 20/200 | — | 3 |
8 | 51 | M | — | 2 | CF | IBF | CF | 20/200 | — | 3 |
9 | 56 | F | Yes | 0.5 | CF | IBF | LP | LP | — | 6 |
10 | 42 | M | — | 30 | 20/50 | MO | 20/25 | 20/200 | — | 22 |
11 | 69 | M | — | 2 | CF | MO | CF | CF | Rubeosis | 15 |
12 | 45 | F | — | 4 | CF | MO | 20/200 | 20/20 | — | 14 |
13 | 85 | M | — | 3 | CF | MO | HM | HM | — | 2 |
14 | 65 | M | — | 5 | 20/100 | MO | 20/100 | 20/200 | — | 7 |
15 | 75 | F | — | 120 | CF | MO | CF | 20/400 | — | 32 |
16 | 58 | M | — | 210 | 20/50 | MO | 20/50 | 20/60 | — | 53 |
17 | 61 | M | Yes | 30 | 20/50 | MO | 20/40 | CF | — | 18 |
18 | 56 | M | — | 60 | 20/100 | MO | 20/100 | 20/100 | — | 71 |
19 | 57 | M | Yes | 90 | 20/50 | MO | 20/50 | 20/400 | NVG | 31 |
20 | 65 | M | — | 60 | 20/400 | MO | 20/400 | 20/400 | 4 | |
21 | 69 | F | Yes | 5 | 20/50 | MO | 20/40 | 20/25 | 6 | |
22 | 52 | M | — | 1 | 20/60 | CR | 20/25 | 20/25 | 34 | |
23 | 73 | M | Yes | 18 | 20/25 | CR | 20/40 | 20/20 | 32 | |
24 | 60 | M | — | 7 | 20/160 | CR | 20/160 | 20/200 | 4 | |
25 | 50 | M | Yes | 2 | CF | SMH | CF | HM | Rubeosis | 3 |
26 | 73 | F | — | 15 | CF | Ischaemia | HM | HM | NVG | 32 |
NVG = neovascular glaucoma; IBF = impairment of retinal blood flow; MO = macular oedema; CR = cilioretinal artery occlusion; SMH = submacular haemorrhage.